Phyllis Chew
- Immunology
- Molecular Biology
- Physiology
- Clinical Biochemistry top 5%
- Cardiology and Cardiovascular Medicine
- Co-authors
- Karin Jandeleit‐DahmMark E. CooperHarald SchmidtRhian M. TouyzKit KennedyStephen P. GrayJudy B. de HaanNada Stefanovic
- Topics
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers)Advanced Glycation End Products research (3 papers)Atherosclerosis and Cardiovascular Diseases (3 papers)
- Partner nations
- AustraliaNetherlandsUnited Kingdom
In The Last Decade
Phyllis Chew
9 papers receiving 538 citations
Peers
Comparison fields: 5 of 70
- Immunology 183
- Molecular Biology 165
- Physiology 161
- Clinical Biochemistry 97
- Cardiology and Cardiovascular Medicine 74
Countries citing papers authored by Phyllis Chew
This map shows the geographic impact of Phyllis Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Chew more than expected).
Fields of papers citing papers by Phyllis Chew
This network shows the impact of papers produced by Phyllis Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Chew. The network helps show where Phyllis Chew may publish in the future.
Co-authorship network of co-authors of Phyllis Chew
This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis Chew. A scholar is included among the top collaborators of Phyllis Chew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis Chew. Phyllis Chew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 89 | |
| 3 | 29 | |
| 4 | 148 | |
| 5 | 53 | |
| 6 | 27 | |
| 7 | 102 | |
| 8 | 73 | |
| 9 | A comparative trial of albendazole, mebendazole, pyrantel pamoate and oxantel pyrantel pamoate against soil-transmitted helminthiases in school children. | 13 |
About Phyllis Chew
Phyllis Chew is a scholar working on Clinical Biochemistry, Toxicology and Nephrology, having authored 9 papers that have together received 541 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Advanced Glycation End Products research (3 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). The work is most often cited by research in Clinical Biochemistry (97 citations), Immunology (183 citations) and Nephrology (56 citations). Phyllis Chew has collaborated with scholars based in Australia, Netherlands and United Kingdom. Frequent co-authors include Karin Jandeleit‐Dahm, Mark E. Cooper, Harald Schmidt, Rhian M. Touyz, Kit Kennedy, Stephen P. Gray, Judy B. de Haan, Nada Stefanovic, Derek Y.C. Yuen and Elyse Di Marco. Their work appears in journals such as Diabetes, Kidney International and Arteriosclerosis Thrombosis and Vascular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.